ZC3H12A and breast cancer: This mechanism was further validated in an in vivo xenograft model, in which high MCPIP1 expression inhibited tumour growth and inhibit breast cancer invasion, while additional treatment of xenografts with low levels of MCPIP1 expression with a TGF-β inhibitor attenuated their growth phenotype.